Effect of Mass Artesunate-Amodiaquine Distribution on Mortality of Patients With Ebola Virus Disease During West African Outbreak.

Stephanie Chow GarbernDerrick YamAdam R AluisioDaniel K ChoStephen B KennedyMoses MassaquoiFoday SahrShiromi M PereraAdam C LevineTao Liu

Published in: Open forum infectious diseases (2019)

There was a non-statistically significantly decreased risk of mortality in EVD patients exposed to ASAQ during the 2 MDAs as compared with EVD patients not exposed to ASAQ. Further prospective trials are needed to determine the direct effect of ASAQ on EVD mortality.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular events
prognostic factors
risk factors
cardiovascular disease
patient reported outcomes